Skip to main content

Table 3 MCID references comparing disease specific to generic PROMs

From: The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada

MCID reported

Disease specific n (%)

Generic n (%)

Total n (%)

No MCID

32 (55)

33 (80)

65 (66)

MCID

26 (45)

8 (20)

34 (34)

Total

58

41

99 (p = 0.009)